Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey
Lancet
S Yusuf, S Islam, CK Chow, S Rangarajan, G Dagenais, R Diaz, R Gupta, R Kelishadi, R Iqbal, A Avezum, A Kruger, R Kutty, F Lanas, L Lisheng, L Wei, P Lopez-Jaramillo, A Oguz, O Rahman, H Swidan, K Yusoff, W Zatonski, A Rosengren, KK Teo
August 2011